Invention Grant
- Patent Title: Clonidine formulation
- Patent Title (中): 可乐定制剂
-
Application No.: US12908796Application Date: 2010-10-20
-
Publication No.: US08623409B1Publication Date: 2014-01-07
- Inventor: Ketan Mehta , Yu-Hsing Tu
- Applicant: Ketan Mehta , Yu-Hsing Tu
- Applicant Address: US NJ Monmouth Junction
- Assignee: Tris Pharma Inc.
- Current Assignee: Tris Pharma Inc.
- Current Assignee Address: US NJ Monmouth Junction
- Agency: Howson & Howson LLP
- Agent Cathy A. Kodroff; Egon Berg
- Main IPC: A61K9/22
- IPC: A61K9/22 ; A61K9/20 ; A61K9/28 ; A61K9/14 ; A61K31/415 ; A01N43/52 ; A01N33/18 ; A01N33/24 ; A61K31/04

Abstract:
An oral clonidine dosage unit providing a twenty-four hour extended release profile following a single dose administration is provided. The dosage unit comprises a pharmaceutically effective amount of a coated complex comprising clonidine bound to a cationic exchange resin, which is characterized by a twenty-four hour release profile with a single peak, wherein said oral clonidine dosage unit provides a therapeutically effective plasma concentration for at least about 70%, or at least 85% of the twenty-four hour period following the single dose administration. Both liquid and solid formulations are provided, as are methods of treating a patient by a single administration of a formulation of the invention so as to achieve a therapeutic effect for 24-hours.
Information query